Dioxane

Dioxane

SCHEMBL25199508

C1COCCO1.CC1CCN(c2ccc(N)cc2)CC1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.52
ALDH1A1 P00352 6/20 0.52
KMT2A Q03164 5/20 0.52
GAA P10253 4/20 0.52
GFER P55789 4/20 0.52
KDM4E B2RXH2 4/20 0.52
ADRA2C P18825 1/20 0.52
PTK2B Q14289 1/20 0.52
ESR2 Q92731 1/20 0.52
USP2 O75604 4/20 0.51
HTT P42858 4/20 0.50
MEN1 O00255 4/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
TP53 P04637 2/20 0.48
ALOX15 P16050 2/20 0.48
HSD17B10 Q99714 2/20 0.48
POLB P06746 1/20 0.48
THRB P10828 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6287835 0.93 MAPT (0.59) MAPTALDH1A1KMT2AGAAGFER
SCHEMBL15650643 0.81 MAPT (0.50) MAPTALDH1A1KMT2AGAAGFER
SCHEMBL16330372 0.81 MAPT (0.50) MAPTALDH1A1KMT2AGAAGFER
SCHEMBL20631313 0.81 LMNA (0.61) MAPTALDH1A1KMT2AGAAGFER
SCHEMBL14320362 0.79 MAPT (0.61) MAPTALDH1A1KMT2AGAAGFER
SCHEMBL20631 0.78 MAPT (0.61) MAPTALDH1A1KMT2AGAAGFER
SCHEMBL24418020 0.77 ALDH1A1 (0.46) MAPTALDH1A1KMT2AGAAGFER
SCHEMBL77976 0.77 L3MBTL3 (0.59) MAPTALDH1A1KMT2AGAAGFER
SCHEMBL3540354 0.77 LGMN (0.77) MAPTALDH1A1KMT2AGAAKDM4E
SCHEMBL17264101 0.77 MAPT (0.59) MAPTALDH1A1KMT2AGAAGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 MAPT 4384/4885ALDH1A1 395/4885KMT2A 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.